LONDON (ShareCast) - (Sharecast News) - Medical imaging tech group Polarean Imaging has announced a new supply agreement with the University of Virginia Health, giving shares of the AIM-listed outfit a bump on Monday.
The agreement covers the implementation of full clinical Xenon MRI capabilities for UVA Health, an integrated health system in Virginia with an academic medical centre that includes a Comprehensive Cancer Center and peadiatric hospital UVA Health Children's.

Having upgraded its two research-grade hyperpolarisers to clinical-grade systems in 2024 provided by Polarean, UVA Health now needs additional equipment to enable clinical Xenon MRI scans in their clinical imaging area.

"We are delighted to support UVA Health as they prepare to launch their first clinical Xenon MRI scan, anticipated to occur later this year. Their deep and sustained commitment to advancing pulmonary imaging - from early research breakthroughs to today's clinical transition - perfectly aligns with Polarean's mission to provide critical imaging solutions for chronic lung disease," said Polarean's chief executive Christopher von Jako.

"UVA Health's decades-long leadership in Xenon MRI has been instrumental in shaping the field, and we look forward to continuing our partnership to improve lung health for patients everywhere."

Shares were 4% higher at 0.52p by 0916 BST.

Email this article to a friend

or share it with one of these popular networks:

• DIGG
• FACEBOOK
• STUMBLEUPON
• MIXX
• YAHOO BUZZ
• DELICIOUS
• REDDIT
• NEWSVINE